Jingping Mei - Shanghai Fosun Vice President

SFOSF Stock  USD 1.67  0.04  2.34%   

President

Jingping Mei is Vice President of Shanghai Fosun Pharmaceutical since 2019.
Age 53
Tenure 5 years
Phone86 21 3398 7000
Webhttps://www.fosunpharma.com

Shanghai Fosun Management Efficiency

The company has return on total asset (ROA) of 0.0204 % which means that it generated a profit of $0.0204 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0756 %, meaning that it generated $0.0756 on every $100 dollars invested by stockholders. Shanghai Fosun's management efficiency ratios could be used to measure how well Shanghai Fosun manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 9.05 B in total debt with debt to equity ratio (D/E) of 0.64, which is about average as compared to similar companies. Shanghai Fosun Pharm has a current ratio of 0.98, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Shanghai Fosun until it has trouble settling it off, either with new capital or with free cash flow. So, Shanghai Fosun's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shanghai Fosun Pharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shanghai to invest in growth at high rates of return. When we think about Shanghai Fosun's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Linda ZukauckasAmerican Express
N/A
Rick PetrinoAmerican Express
N/A
Anna MarrsAmerican Express
47
Neal SampleAmerican Express
39
Richard PetrinoAmerican Express
56
Ashwini GuptaAmerican Express
62
James BushAmerican Express
57
Paul AbbottAmerican Express
N/A
Michael OneillAmerican Express
64
John HayesAmerican Express
60
Laureen SeegerAmerican Express
62
Paul FabaraAmerican Express
52
Susan SobbottAmerican Express
51
Elizabeth RutledgeAmerican Express
62
Denise PickettAmerican Express
55
Marc GordonAmerican Express
59
Shanghai Fosun Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. Shanghai Fosun Pharmaceutical Co., Ltd. was founded in 1994 and is based in Shanghai, China. Shanghai Fosun operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 36604 people. Shanghai Fosun Pharmaceutical [SFOSF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Shanghai Fosun Pharm Leadership Team

Elected by the shareholders, the Shanghai Fosun's board of directors comprises two types of representatives: Shanghai Fosun inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Fosun's management team and ensure that shareholders' interests are well served. Shanghai Fosun's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Fosun's outside directors are responsible for providing unbiased perspectives on the board's policies.
Minqiao Li, Non-Executive Independent Director
Yao Wang, Vice President
Tianyou Huang, Independent Non-Executive Director
Biao Zhou, Sr. VP, General Manager of Legal Department and Joint Company Secretary
Haining Mu, Non-Executive Director
Jianfeng Liang, Non-Executive Director
Shaokun Wei, Independent Non-Executive Director
Weijiong Zhang, Non-Executive Independent Director
Xian Jiang, Independent Non-Executive Director
Yuqing Chen, Senior Vice President
Jiong Han, Non-Executive Independent Director
Yaoyi Zhu, Vice President
Huimin Cao, Independent Non-Executive Director
Guang Guo, Founder, Non Executive Director and Member of Strategic Committee
Yifang Wu, President CEO
Zhichao Dong, Vice President
Deyong Wen, Vice President
Jianglin Hu, Vice President
Jiayu Shi, Vice President
Jia Yan, Director Department
Xiaoxian Dong, Vice President Secretary of the Board
Dongming Li, Vice President
Shengli Li, Ex Pres
Yuejian Zhang, Vice President
Xiaowei Ni, Vice President
Xinmin Zhang, Senior Vice President
Guozheng Zhang, Non-Executive Director
Changzheng Ma, Senior Vice President
Hongfei Jia, CFO and Sr. VP
Qi Chen, Executive Chairman, Chairman of Strategic Committee and Member of Remuneration and Appraisal Committee
Yi Liu, Vice President
Chun Li, Senior Vice President
Fang Yao, Vice Chairman, CEO and President General Manager and Member of Strategic Committee
Lan Kang, Non-Executive Director
Aimin Hui, Senior Vice President
Xiaolei Wu, VP CFO
Hequn Yin, Senior Vice President
Qunbin Wang, Non-Executive Director
Xiaoliang Xu, Non-Executive Director
Cheng Wang, Senior Vice President
Guliang Tang, Independent Non-Executive Director
Can Wang, Non-Executive Director
Kexin Wang, Vice President
Jinsong Song, Senior Vice President
Qiyu Chen, Executive Chairman, Chairman of Strategic Committee and Member of Remuneration and Appraisal Committee
Donghua Wang, Vice President
Guangchang Guo, Founder, Non Executive Director and Member of Strategic Committee
Zhiping Cui, Vice President
Xiaojun Ding, Vice President
Ying Shao, Vice President
Dongjiu Li, Senior Vice President
Yimin Guan, Non-Executive Independent Director
Jingping Mei, Vice President
Xiaohui Guan, CFO and Sr. VP

Shanghai Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shanghai Fosun a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Shanghai Fosun in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Shanghai Fosun's short interest history, or implied volatility extrapolated from Shanghai Fosun options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shanghai Fosun Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Shanghai Pink Sheet analysis

When running Shanghai Fosun's price analysis, check to measure Shanghai Fosun's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Fosun is operating at the current time. Most of Shanghai Fosun's value examination focuses on studying past and present price action to predict the probability of Shanghai Fosun's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Fosun's price. Additionally, you may evaluate how the addition of Shanghai Fosun to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Please note, there is a significant difference between Shanghai Fosun's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shanghai Fosun is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shanghai Fosun's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.